NEDD4L and metastatic malignant neoplasm in the lymph nodes: In addition, further analysis confirmed that low expression of NEDD4L (p < 0.05), invasion (p < 0.05) and lymph node metastasis (p < 0.05) are risk factors for poor prognosis (Table 2).